Iron—cytochrome-c reductase
Iron—cytochrome-c reductase, also known as complex III or the cytochrome bc1 complex, is a crucial enzyme in the electron transport chain, playing a vital role in cellular respiration and energy production within the mitochondrion. This enzyme facilitates the transfer of electrons from ubiquinol (QH2) to cytochrome c, a process that is essential for the synthesis of adenosine triphosphate (ATP), the energy currency of the cell.
Structure and Function[edit | edit source]
Iron—cytochrome-c reductase is a multi-subunit complex embedded in the mitochondrial inner membrane. It consists of several protein subunits, including cytochromes b and c1, and the Rieske protein. The complex operates through the Q-cycle, a mechanism that efficiently transfers electrons and contributes to the generation of a proton gradient across the mitochondrial membrane. This proton gradient is then used by ATP synthase to produce ATP.
The activity of iron—cytochrome-c reductase is regulated by the availability of its substrates, ubiquinol and cytochrome c, and is influenced by the proton motive force across the mitochondrial membrane. Inhibitors of this complex, such as antimycin A, can disrupt cellular respiration and ATP production, highlighting the enzyme's critical role in metabolic processes.
Clinical Significance[edit | edit source]
Dysfunction of iron—cytochrome-c reductase can lead to a variety of mitochondrial diseases, as it impairs the cell's ability to produce ATP efficiently. Mutations in genes encoding the subunits of the complex or factors involved in its assembly can result in diseases such as Leigh syndrome and mitochondrial complex III deficiency, which are characterized by a wide range of symptoms, including neurodegeneration, muscle weakness, and organ failure.
Research into iron—cytochrome-c reductase has also provided insights into the mechanisms of apoptosis (programmed cell death) and the development of drugs that can target the electron transport chain in cancer cells, offering potential therapeutic strategies for cancer treatment.
See Also[edit | edit source]
References[edit | edit source]
 | This enzyme-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
